Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan

The role of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) in the pandemic context of coronavirus disease 2019 (COVID-19) continues to be debated. Patients with hypertension, diabetes mellitus, chronic renal failure, cerebro-cardiovascular disease, or chro...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of cardiology 2022-10, Vol.80 (4), p.292-297
Hauptverfasser:	Yoshihara, Fumiki, Ohtsu, Hiroshi, Nakai, Michikazu, Tsuzuki, Shinya, Hayakawa, Kayoko, Terada, Mari, Matsunaga, Nobuaki, Yasuda, Satoshi, Ogawa, Hisao, Ohmagari, Norio
Format:	Artikel
Sprache:	eng
Schlagworte:	Associated factors COVID-19 Disease outcome Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!